A Medical Device Daily
Codman & Shurtleff (C&S; Raynham, Massachusetts) reported that Cordis Neurovascular, a subsidiary of Cordis (Miami Lakes, Florida), has become a business unit of Codman. C&S said the new business unit, renamed Codman Neurovascular (Raynham), greatly expands its presence in global neurosciences and stroke management and marks its entry into the neurovascular marketplace.
Codman Neurovascular offers a portfolio of neurovascular coils, catheters, liquid embolics and vascular reconstruction devices for the minimally invasive treatment of aneurysms and cerebral arteriovenous malformations.
Codman, part of the DePuy (Raynham) family of companies within Johnson & Johnson (New Brunswick, New Jersey), which also owns Cordis, is a global neuroscience company that offers a wide range of neurological devices and solutions including programmable shunt systems to treat hydrocephalus, trauma monitoring devices for critical care and drug pumps for pain.
As a total neuroscience company, Codman said it will deliver current and future technologies to a wide range of health professionals including neurosurgeons, neurologists, interventional neuro radiologists and pain management specialists.